Background {#Sec1}
==========

Pancreatic panniculitis is a rare skin manifestation associated with pancreatic disorders that presents in approximately 3% of patients with acute or chronic pancreatic disease \[[@CR1]\]. The disorder most commonly develops on the lower legs as ill-defined erythematous subcutaneous nodules. Such nodules are detected in up to 45% of patients with pancreatic panniculitis before recognition of the original pancreatic disease \[[@CR1]\]. Accordingly, the chief complaint of the patient is sometimes erythematous nodule detection before abdominal symptoms. Clinicians therefore have the risk of overlooking the underlying pancreatic disease. We herein report the rare case of a 68-year-old man who had pancreatic panniculitis on his trunk associated with acute pancreatitis due to an intraductal papillary mucinous neoplasm (IPMN).

Case presentation {#Sec2}
=================

A 68-year-old male patient was referred to our hospital by his primary care physician for further evaluation of a painful subcutaneous nodule on his upper middle abdomen, which was suspected to be abdominal cellulitis. Five days before admission, he had suffered from epigastralgia, nausea, and anorexia. Four days before admission, his epigastralgia had improved. Two days prior to admission, he noticed an erythematous nodule on his abdomen. His chief complaint on admission to our hospital was the painful nodule on his abdomen. He had been under medical treatment with aspirin, atorvastatin, colestimide, nicorandil, and famotidine for past medical histories of coronary artery bypass grafting (CABG), appendectomy, and dyslipidemia. He had no allergies. He had smoked 1 pack per day for 33 years before quitting 15 years earlier. He habitually drank 20 g of ethanol per day, with no history of heavy drinking. On examination, his temperature was 38.8 °C, blood pressure was 144/74 mmHg, and pulse was 98/min with regular rhythms. A painful and tender erythematous nodule was palpable on his epigastrium at the lower edge of a postoperative scar from CABG. The nodule was 2.5 cm in diameter and surrounded by pale erythema (Fig. [1](#Fig1){ref-type="fig"}a). Laboratory tests revealed a white blood cell count elevation of 15,650/μL along with a C-reactive protein (CRP) abnormality of 24.4 mg/dL, with no amylase or lipase elevation (Table [1](#Tab1){ref-type="table"}). Abdominal contrast computed tomography (CT) confirmed grade 1 acute pancreatitis (Fig. [2](#Fig2){ref-type="fig"}a) and a 20 mm multifocal cystic mass at the pancreatic body along with an 8 mm dilation of the main pancreatic duct, which were compatible with a diagnosis of IPMN (Fig. [2](#Fig2){ref-type="fig"}b). Thereafter, he commenced intravenous fluid infusion and antibiotic therapy. On hospital day 3, he became afebrile and showed improvements in inflammatory clinical parameters. A punched biopsy of the skin lesion on hospital day 4 revealed lobular panniculitis without vasculitis findings. Histological analysis uncovered focal necrosis of adipocytes and "ghost-like" cells with calcification surrounded by neutrophil-rich inflammatory infiltration, which indicated pancreatic panniculitis (Fig. [3](#Fig3){ref-type="fig"}). Intravenous fluid infusion and antibiotic therapy were continued until discharge on hospital day 12 for nodule pain disappearance along with CRP normalization. The erythematous nodule on his abdomen disappeared 1 week afterwards (Fig. [1](#Fig1){ref-type="fig"}b). The patient has been complaint-free without nodule recurrence or additional nodule appearance since his discharge 2 years prior. His IPMN status is routinely monitored every 3 months by imaging studies. Fig. 1**a** An erythematous reddish subcutaneous nodule on the abdomen causing spontaneous pain and tenderness on admission (arrowheads). **b** The nodule disappeared 1 week after discharge, leaving only the biopsy scar (arrowheads)Table 1Laboratory data on admission\<Hematology\>\<Chemistry\>\<Tumor markers\>While blood cell15,650/μLTotal Protein6.0g/dLCEA2.9ng/mLNeutrophil84.5%Albumin2.5g/dLCA19--92U/mLRed blood cell504 × 10^4^/μLAST27U/LHemoglobin15.5g/dLALT31U/L\<Arterial blood gas\>Platelet count20.7 × 10^4^/μLLDH363U/LpH7.503ALP357U/LpCO~2~29.3mmHg\<Coagulation\>GGT75U/LpO~2~62.1mmHgProthrombin %90%Total Bilirubin1.0mg/dLHCO~3~^−^22.8mmol/LPT-INR1.06BUN15.3mg/dLBE1.1mmol/LActivated partial thromboplastin time31.8secCre0.73mg/dLLactate0.6mmol/LNa135mEq/LK3.3mEq/LcCa9.2mEq/LAMY73U/LLipase38U/LCRP24.4mg/dLAbbreviations: *Alb* Albumin; *ALP* Alkaline phosphatase; *ALT* Alanine aminotransferase; *AMY* Amylase; *APTT* Activated partial thromboplastin time; *AST* Aspartate aminotransferase; *BE* Base excess; *BUN* Blood urea nitrogen; *CA19--9* Carbohydrate antigen 19--9; *cCa* Corrected calcium; *CEA* Carcinoembryonic antigen; *Cre* Creatinine; *CRP* C-reactive protein; *GGTP* Gamma-glutamyltranspeptidase; *Hb* Hemoglobin; *LDH* Lactate dehydrogenase; *Neut*, neutrophils; *PT*, prothrombin time; *INR* International normalized ratio; *T-Bil* Total bilirubin; *TP* Total protein; *RBC* Red blood cells; *WBC* White blood cellsFig. 2**a** Abdominal contrast CT on admission demonstrated a swollen pancreas with surrounding fat strands (arrowheads). **b** The CT showed a 20 mm multifocal cystic mass at the pancreatic body (arrowheads) along with an 8 mm dilation of the main pancreatic duct (arrow)Fig. 3**a** A punched biopsy of the skin lesion revealed lobular panniculitis with focal necrosis of adipocytes. (hematoxylin and eosin staining, × 2 magnification. **b** The biopsy showed "ghost-like" cells with calcification surrounded by neutrophil-rich inflammatory infiltration (arrow). (hematoxylin and eosin staining, × 10 magnification)

Discussion and conclusions {#Sec3}
==========================

Pancreatic panniculitis is a rare skin manifestation associated with pancreatic disease. In the clinical setting, panniculitis is noticed as erythematous, ill-defined, and/or red-brown nodules \[[@CR2]\] that generally affect the lower limbs and buttocks, rarely the trunk and upper extremities \[[@CR3]\]. Only 9 cases have been described of pancreatic panniculitis on the trunk \[[@CR3]--[@CR11]\]. We encountered a unique case of subcutaneous nodules on the abdomen with latent IPMN. Skin biopsy revealed the typical histological findings of pancreatic panniculitis of lobular neutrophilic necrotizing panniculitis intermingled with specific necrotic anucleate adipocytes, called "ghost cells" \[[@CR12]\].

The mechanism of pancreatic panniculitis onset remains unknown. It is hypothesized that systemically released pancreatic enzymes such as amylase and lipase can cause lipolysis and fat necrosis \[[@CR13], [@CR14]\], resulting in pancreatic panniculitis as a specific clinical phenotype. However, several cases of pancreatic panniculitis with normal serum pancreatic enzymes have been reported \[[@CR15], [@CR16]\], as in the present case. One possible reason for our patient was that his pancreatic amylase had already peaked due to pancreatitis improvement since such pancreatitis symptoms as epigastralgia had improved 4 days before admission. Therefore, it is clinically important to consider pancreatic panniculitis in patients with subcutaneous nodules even in the absence of abdominal symptoms for underlying pancreatic disorders, regardless of pancreatic enzyme status. This may avoid a missed or significantly delayed diagnosis of primary pancreatic disease.

The main pancreatic diseases related to pancreatic panniculitis have been reported as acute or chronic pancreatitis, pancreatic carcinoma (ductal adenocarcinoma, acinar cell carcinoma, or neuroendocrine carcinoma), and IPMN. In the present case, the underlying pancreatic disease was acute pancreatitis due to IPMN. Zundler et al. reviewed that subcutaneous lesions were noted prior to the diagnosis of pancreatic disease in 48.9% of reported cases \[[@CR3]\]. In terms of clinical course, the period between subcutaneous lesion appearance and the detection of abdominal disorders could be several months for pancreatic panniculitis \[[@CR17]\]. Table [2](#Tab2){ref-type="table"} summarizes the literature on pancreatic panniculitis displaying subcutaneous nodules as a chief complaint before diagnosing pancreatic disease. We searched the English-written literature between 1994 and 2019 using the parameters "pancreatic panniculitis" and "subcutaneous fat necrosis AND pancreas" in PubMed to identify 56 reported cases. The site of the nodules was predominantly the leg, with some cases on the trunk or arm. It should be noted that the period between subcutaneous lesion appearance and detection of the pancreatic disease was up to 48 weeks, and the underlying pancreatic disorder was a pancreatic neoplasm in nearly half of patients. Of all reported cases summarized in Table [2](#Tab2){ref-type="table"}, only 2 were described as latent IPMN presenting as pancreatic panniculitis \[[@CR22], [@CR41]\]. Pancreatic panniculitis could therefore serve as the impetus for an intensive search for pancreatic neoplasms in order to prevent a potentially long delay in diagnosis \[[@CR17], [@CR60]\]. Table 2Reported cases of pancreatic panniculitis with subcutaneous nodule(s) as a chief complaintAge\
(years)SexNodule sitePeriod preceding diagnosis\
(weeks)Amylase\
(U/L)Lipase\
(U/L)Pancreatic diseaseReference77MLeg2WNL6027Pancreatic carcinoma\[[@CR18]\]64MLeg330526205Pancreatic acinar cell carcinoma\[[@CR19]\]50MLeg4111327,500Pancreatic acinar cell carcinoma\[[@CR20]\]67MTrunk, leg045443885Chronic pancreatitis\[[@CR4]\]57MLeg16216127,575Pancreatic carcinoma\[[@CR21]\]61FLeg12148N/DIPMN\[[@CR22]\]76MLeg12000400Acute pancreatitis\[[@CR23]\]34FLeg26502893Pancreas allograft rejection\[[@CR24]\]73FTrunk, leg8WNL14,747Pancreatic acinar cell carcinoma\[[@CR3]\]86FLeg4N/D870Pancreatic carcinoma\[[@CR25]\]55MLeg448N/DPancreatic neuroendocrine carcinoma\[[@CR26]\]63MArm, leg0.366473000Acute pancreatitis\[[@CR12]\]49MLeg4Over NLN/DAcute pancreatitis\[[@CR27]\]71FLeg410731871Chronic pancreatitis\[[@CR28]\]66FLeg4N/D3000Acute pancreatitis\[[@CR29]\]54MLeg36WNL9018Pancreatic acinar cell carcinoma\[[@CR30]\]2MTrunk, leg0.7430N/DAcute pancreatitis\[[@CR5]\]35MLeg, buttock43 × ULNN/DChronic pancreatitis\[[@CR31]\]50MLeg319092306Acute pancreatitis\[[@CR17]\]79FLeg16WNLN/DPancreatic acinar cell carcinoma\[[@CR32]\]34MTrunk, leg449001400Chronic pancreatitis\[[@CR6]\]49MTrunk, arm01248N/DAcute pancreatitis\[[@CR7]\]61FArm, leg0241515Acute pancreatitis\[[@CR33]\]39MTrunk, leg2Over NLOver NLChronic pancreatitis\[[@CR8]\]17FLeg0.38291330Acute pancreatitis\[[@CR34]\]63FLeg16WNL8000Metastatic pancreatic adenocarcinoma\[[@CR35]\]82MLeg2Over NLOver NLPancreatic acinar cell carcinoma\[[@CR36]\]18FLeg01631333Acute pancreatitis\[[@CR37]\]69MLeg8941,405Metastatic pancreatic adenocarcinoma\[[@CR38]\]79MLeg8WNL4668Metastatic pancreatic NEC\[[@CR39]\]68MLeg04116,022Metastatic pancreatic NEC\[[@CR40]\]75MLeg05424,060Pancreatic adenocarcinoma\[[@CR40]\]67FLeg10N/DN/DIPMN\[[@CR41]\]72MLeg12N/DOver NLPancreatic NEC\[[@CR42]\]42FLeg2.819833550Acute pancreatitis\[[@CR43]\]53MLeg0225216,000Acute pancreatitis\[[@CR44]\]59FLeg03000N/DAcute pancreatitis\[[@CR45]\]81MLeg, trunk, buttock48WNL6430Pancreatic acinar cell carcinoma\[[@CR9]\]49MLeg4Over NLN/DAcute pancreatitis\[[@CR27]\]66MLeg228446265Pancreatic acinar cell carcinoma\[[@CR46]\]69MLeg6WNL1326Pancreatic acinar cell carcinoma\[[@CR47]\]75MLeg20WNL62,650Pancreatic tumor\[[@CR48]\]39MLeg13631355Chronic pancreatitis with pseudocyst\[[@CR48]\]54FLeg16181511,935Chronic pancreatitis\[[@CR49]\]47FLeg2N/D562Acute pancreatitis\[[@CR50]\]46FLeg0Over NLN/DChronic pancreatitis\[[@CR51]\]61FArm, leg0WNL13,510Metastatic acinar cell carcinoma\[[@CR52]\]77FLeg148104901Acute pancreatitis\[[@CR53]\]68MLeg32470016,000Chronic pancreatitis\[[@CR54]\]19FTrunk, leg0869759Solid pseudopapillary tumor of the pancreas\[[@CR10]\]54MArm, leg0.610367231Acute pancreatitis\[[@CR55]\]76MTrunk024612488Acute pancreatitis\[[@CR11]\]82MArm, leg48457674Pancreatic tumor\[[@CR56]\]47MLeg215391516Pancreatic adenocarcinoma\[[@CR57]\]66MLeg120363538Acute pancreatitis\[[@CR58]\]48MLeg145003500Chronic pancreatitis\[[@CR59]\]68MTrunk0.373N/DIPMNPresentcaseAbbreviations: *M* Male; *F* Female; *N/D* Not described; *Over NL* Over normal limit; *ULN* Upper limit of normal; *IPMN* Intra-ductal papillary mucinous neoplasm; *WNL* Within normal limit; *NEC* Neuroendocrine carcinoma

In conclusion, clinicians should bear in mind that pancreatic panniculitis can be the chief complaint of pancreatic disease when encountering subcutaneous nodules on the trunk to prevent a missed or delayed diagnosis.
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